Tumor necrosis factor-alpha in ileal mast cells in patients with Crohn's disease

Digestion

Volumn 61, Issue 1, 2000, Pages 68-76

  Lilja, I ^a   Gustafson Svard C ^a,b   Franzen L ^c   Sjodahl R ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Crohn's disease; Inflammatory bowel disease; Mast cell; Mucosa; Muscularis propria; Submucosa; Tumor necrosis factor

Indexed keywords

TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; ILEITIS; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE WALL; LAMINA PROPRIA; MALE; MAST CELL; PRIORITY JOURNAL; SUBMUCOSA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CELL COUNT; CROHN DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; ILEITIS; ILEUM; IMMUNOENZYME TECHNIQUES; MALE; MAST CELLS; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033975691     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007737     Document Type: Article

References (37)

1. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, De Woody KL, Schaible TF, Rutgeerts PJ: A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease: Crohn's disease cA2 Study Group. N Engl J Med 1997;337:1029-1035.
2. Ming WJ, Bersani L, Mantovani A: Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 1987;138:1469-1074.
3. Furuta GT, Schmidt-Choudhury A, Wang M-Y, Wang Z-S, Lu L, Furlano RI, Wershil BK: Mast cell-dependent tumor necrosis factor α production participates in allergic gastric inflammation in mice. Gastroenterology 1997; 113:1560-1569.
4. Munro JM, Pober JS, Cotran RS: Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Pathol 1989;135:121-133.
5. Mullin JM, Snock KV: Effect of tumor necrosis factor on epithelial tight junctions and trans-epithelial permeability. Cancer Res 1990;50: 2172-2176.
6. Gamble JR, Smith WB, Vadas MA: TNF modulation of endothelial and neutrophil adhesion; in Beutler B (ed): Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. New York, Raven Press, 1992, pp 65-86.
7. Clauss M, Ryan J, Stern D: Modulation of endothelial cell hemostatic properties by TNF: Insights into the role of endothelium in the host response to inflammatory stimuli; in Beutler B (ed): Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. New York, Raven Press, 1992, pp 49-63.
8. Kindler V, Sappino A-P, Grau GE, Piguet PF, Vassalli P: The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56: 731-740.
9. Kendall JC, Li X-H, Galli SJ, Gordon JR: Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: Role for mast cell tumor necrosis factor-α and transforming growth factor-B 1. J Allergy Clin Immunol 1997;99:113-123.
10. 2-stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 1993;28:323-330.
11. Reinecker H-C, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raidler A: Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1B by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-181.
12. Reimund J-M, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, Poindron P, Duclos B: Increased production of tumour necrosis factor-α, interleukin-lB, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996;39:684-689.
13. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT: Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992;339:89-91.
14. Wershil BK, Wang Z-S, Gordon JR, Galli SJ: Recruitment of neutrophils during IgE-dependent cutaneous late phase reaction in the mouse is mast cell-dependent: Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 1991;87:446-453.
15. Lloyd G, Green FHY, Fox H, Mani V, Turnberg LA: Mast cells and immunoglobulin E in inflammatory bowel disease. Gut 1975;16: 861-866.
16. Dvorak AM, Monahan RA, Osage JE, Dickersin GR: Crohn's disease: Transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum Pathol 1980;11:606-619.
17. Dvorak AM, Monahan RA: Crohn's disease - mast cell quantitation using one micron plastic sections for light microscopic study; in Rosén PP (ed): Pathology Annual. New York, Sommers SC, 1983, vol 1, pp 181-190.
18. Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, Maschek H, Stolte M, Gebel M, Manns MP: Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1-13.
19. Knutson L, Ahrenstedt Ö, Odlind B, Hällgren R: The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology 1990;98:849-854.
20. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF: Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88: 4220-4224.
21. Bradding P, Roberts JA, Britten KM, Montefort S: Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-480.
22. Bradding P, Mediwake R, Feather IH, Madden J, Church MK, Holgate ST, Howarth PH: TNFα is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995;25:406-415.
23. Anderson WH, Davidson TM, Broide DH: Mast cell TNF mRNA expression in nasal mucosa demonstrated by in situ hybridization: A comparison of mast cell detection methods. J Immunol Meth 1996;189:145-155.
24. Okayama Y, Semper A, Hogate ST, Church MK: Multiple cytokine mRNA expression in human mast cells stimulated via FcεRI. Int Arch Allergy Immunol 1995;107:158-159.
25. Beil WJ, Weller PF, Peppercorn MA, Galli SJ, Dvorak AM: Ultrastructural immunogold localization of subcellular sites of TNF-α in colonic Crohn's disease. J Leukocyte Biol 1995; 58:284-298.
26. Lilja I, Gustafson-Svärd C, Franzén L, Sjödahl R: Tumour necrosis factor-α in ileal mast cells in patients with Crohn disease. Digestion 1998; 59(suppl3):116.
27. Aldenborg F, Enerbäck L: The immunohistochemical demonstration of chymase and tryptase in human intestinal mast cells. Histochem J 1994;26:587-596.
28. Gordon JR, Galli SJ: Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI: A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J Exp Med 1991;174:103-107.
29. Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, Scott H: Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 1997;112:1493-1505.
30. Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, Walker-Smith JA, MacDonald TT: Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106:1455-1466.
31. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT: Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993;34: 1705-1709.
32. Dionne S, Hiscott J, Dágata I, Duhaime A, Seidman EG: Quantitative PCR analysis of TNF-α and IL-1B mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci 1997;42: 1557-1566.
33. Saiki T, Mitsuyama K, Toyonaga A, Ishida H, Tanikawa K: Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol 1998;33:616-622.
34. Deren JJ, Bai C, Sohn M, Contreras F, DeMondesert T, Just R, Oppenheim D, Schechter NM, Whitaker-Menezes D, Weinbaum G: Accumulation of mast cells and proteinases in the bowel wall in Crohn's disease but not in ulcerative colitis. Gastroenterology 1996;110:A893.
35. Goldsmith P, McGarity B, Walls AF, Church MK, Millward-Sadler GH, Robertson DAF: Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci 1990;35:1409-1413.
36. Shanahan F, Niederlehner A, Carramanzana N, Anton P: Sulfasalazine inhibits the binding of TNFα to its receptor. Immunopharmacology 1990;20:217-224.
37. Bissonnette EY, Enciso JA, Befus AD: Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-α production by mast cells. J Immunol 1996;156:218-237.